Aidence
AI-powered clinical applications for the lung cancer pathway
Founded in 2015, Aidence was a radiology AI company focused on clinical solutions for pulmonary nodule management in routine practice and lung cancer screening.
The company developed and deployed AI clinical applications to empower radiologists and other physicians in interpreting medical images. Their first commercialized product, Veye Lung Nodules (now DeepHealth Lung) was an AI-based solution for lung nodule detection classification, quantification, and growth assessment. This solution has been CE marked in Europe.
Aidence was acquired in 2022 by RadNet, Inc., a leading provider of diagnostic imaging in the United States, then integrated into DeepHealth, a wholly owned subsidiary of RadNet.
